Related Experiment Video
Updated: May 21, 2026

08:27
The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse
Published on: July 25, 2011
Brain protection therapy in acute cerebral infarction
Ken-ichiro Katsura1, Satoshi Suda, Arata Abe
1Department of Neurological, Nephrological and Rheumatological Sciences, Graduate School of Medicine, Nippon Medical School, Sendagi, Tokyo, Japan. k-katsur@nms.ac.jp
Summary
New brain protection strategies for cerebral infarction are needed. Combination drug therapy and hydrogen gas inhalation show promise in extending treatment windows and reducing ischemic damage.
Area of Science:
- Neuroscience
- Pharmacology
- Biomedical Engineering
Background:
- Cerebral infarction treatments effective in animal models often fail in human clinical trials, necessitating novel therapeutic approaches.
- Current brain protection strategies include extending thrombolytic therapy windows, mitigating side effects, and developing alternative therapies for patients with contraindications.
Purpose of the Study:
- To investigate novel therapeutic strategies for brain protection against cerebral infarction.
- To evaluate the efficacy of combination drug therapy and hydrogen gas inhalation in preclinical models.
Main Methods:
- Combination therapy with two established drugs was administered with a time-lag approach.
- Hydrogen gas inhalation therapy was assessed for its potential to mitigate cerebral ischemic damage.
Main Results:
- Combination therapy demonstrated efficacy in protecting the brain and successfully extended the therapeutic time window.
- Hydrogen gas inhalation therapy proved effective in reducing cerebral ischemic damage, even within the ischemic core.
Conclusions:
- Combination therapy represents a viable strategy to enhance treatment efficacy and broaden the therapeutic window for cerebral infarction.
- Hydrogen gas inhalation offers a promising new avenue for brain protection in cerebral infarction, addressing damage in critical ischemic areas.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Transient Ischemic Attack l: Introduction
A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...

